APA

Sato M., Nakai Y., Nakata W., Yoshida T., Hatano K., Kawashima A., Fujita K., Uemura M., Takayama H. & Nonomura N. (20140527). EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. : PloS one.

Chicago

Sato Mototaka, Nakai Yasutomo, Nakata Wataru, Yoshida Takahiro, Hatano Koji, Kawashima Atsunari, Fujita Kazutoshi, Uemura Motohide, Takayama Hitoshi and Nonomura Norio. 20140527. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. : PloS one.

Harvard

Sato M., Nakai Y., Nakata W., Yoshida T., Hatano K., Kawashima A., Fujita K., Uemura M., Takayama H. and Nonomura N. (20140527). EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. : PloS one.

MLA

Sato Mototaka, Nakai Yasutomo, Nakata Wataru, Yoshida Takahiro, Hatano Koji, Kawashima Atsunari, Fujita Kazutoshi, Uemura Motohide, Takayama Hitoshi and Nonomura Norio. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. : PloS one. 20140527.